nextpointtx.comHealthcare / BioTech & PharmaFounded: 2020Funding to Date: $163.11MM
NextPoint Therapeutics, Inc. is a clinical-stage biotechnology firm that is developing precision oncology therapeutics. NextPoint Therapeutics' commitment to pioneering new avenues in cancer treatment, aiming to create therapies that are more effective and less invasive, potentially offering new alternatives to patients with various types of cancer. Their approach is grounded in precision medicine, seeking to tailor treatments that can directly target cancer cells while minimizing harm to healthy tissues
View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like NextPoint.
Become part of the Secondary Marketplace, catering to both individual and institutional investors.